Drug Discovery · Redwood City, CA · Founded 2019 · In IPO Registration
Developer of therapeutic medicines designed to provide curative treatments for serious viral and liver diseases. Bluejay Therapeutics is based in Redwood City, CA and was founded in 2019. Its last known valuation is $820 million. It has raised $243 million across 3 recorded rounds; the latest was an $182 million Series C in May 2024.
Last price · $/share
—
Implied valuation
$820.0M
Total raised
$243.0M
Last round
Later Stage VC (Series C)
May 2024
Cap table — not yet on record
Bluejay Therapeutics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Bluejay Therapeutics with a free account
·The complete investor list: 13 names
·Watch Bluejay Therapeutics: the Monday email on marks, rounds and moves
Where does Bluejay Therapeutics's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Bluejay Therapeutics's 3 recorded funding rounds.
